Home › Funds › Arkadios Wealth Advisors › JNJ

Arkadios Wealth Advisors position in JNJ

JOHNSON & JOHNSON · Health Care

Arkadios Wealth Advisors reported holding 114,657 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$29.1M, representing 0.55% of its reported portfolio and ranking #25 among its reported holdings. Arkadios Wealth Advisors has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)114.66K sh
Reported value held$29.12M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Arkadios Wealth Advisors's JNJ position evolved

Arkadios Wealth Advisors first disclosed a stake in JNJ in Q3 2023 at 71,925 shares (US$11.2M). The position peaked in Q2 2026 at 114,657 shares, worth US$29.1M. Across 12 filings, Arkadios Wealth Advisors increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 114,657 shares valued at US$29.1M — an increase of 114,557 shares quarter over quarter.. Notable position changes include a 42% increase in Q4 2025 (shares rose 18% over the following quarter), a 100% trim in Q1 2026 (shares rose 4% over the following quarter), a 114557% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 71.92K $11.20M New
Q4 2023 77.00K $12.07M Add
Q1 2024 79.89K $12.64M Add
Q2 2024 91.46K $13.37M Add
Q3 2024 61.47K $9.96M Reduce
Q4 2024 46.19K $6.68M Reduce
Q1 2025 60.83K $10.09M Add
Q2 2025 75.03K $11.46M Add
Q3 2025 79.57K $14.75M Add
Q4 2025 112.66K $23.31M Add
Q1 2026 100 $24.44K Reduce
Q2 2026 114.66K $29.12M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Arkadios Wealth Advisors held JNJ?

Arkadios Wealth Advisors has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Arkadios Wealth Advisors's current position in JNJ?

As of Q2 2026, Arkadios Wealth Advisors holds 114.66K shares of JNJ (JOHNSON & JOHNSON), valued at $29.12M, representing 0.55% of its reported portfolio and ranking #25.

Has Arkadios Wealth Advisors been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Arkadios Wealth Advisors increased its position in JNJ. The position peaked in Q2 2026 at 114.66K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.